The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Clinical trial NCT07093346 · RECRUITING

Trial details

NCT number: NCT07093346
Sponsor: University of Nottingham
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD NAFLD Metabolic Dysfunction-Associated Steatotic Liver Disease NAFLD (Nonalcoholic Fatty Liver Disease)NAFLD (Non-alcoholic Fatty Liver Disease)NAFLD - Non-Alcoholic Fatty Liver Disease NAFLD - Nonalcoholic Fatty Liver Disease

Start date: 2025-06-10
Primary completion: 2027-03-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.